The Affordable Care Act has gotten its fair share of media coverage since passing in December of 2009, but much of the discussion has focused the behemoth law’s more controversial aspects, like the individual mandate and Medicaid expansion. One under-discussed provision of the A.C.A. is called “The Sunshine Act.” It's designed to reveal the substantial fees and gifts doctors receive from pharmaceutical and medical device companies.
Joining me to discuss the provision and what it will mean for doctors and companies is healthcare reporter for the Wall Street Journal Peter Loftus, as well as physician and author Danielle Ofri, who writes about medicine and the doctor-patient connection for The New York Times.
